Unknown

Dataset Information

0

Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue.

ABSTRACT: The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. Here we develop and validate a method to amplify Asyn fibrils extracted from LBD postmortem tissue samples and use solid state nuclear magnetic resonance (SSNMR) studies to determine atomic resolution structure. Amplified LBD Asyn fibrils comprise a mixture of single protofilament and two protofilament fibrils with very low twist. The protofilament fold is highly similar to the fold determined by a recent cryo-electron microscopy study for a minority population of twisted single protofilament fibrils extracted from LBD tissue. These results expand the structural characterization of LBD Asyn fibrils and approaches for studying disease mechanisms, imaging agents and therapeutics targeting Asyn.

SUBMITTER: Dhavale DD 

PROVIDER: S-EPMC10980826 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. Here we develop and validate a method to amplify Asyn fibrils extracted from LBD postmortem tissue samples and use solid state nuclear magnetic resonance (SSNMR) studies to determine atomic resolution structure. Amplified LBD Asyn fibrils comprise a mixture of single protofilament and two protofilament fibrils with very low twist. The  ...[more]

Similar Datasets

Unknown Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue.
| S-EPMC9882085 | biostudies-literature
Unknown <sup>13</sup>C and <sup>15</sup>N resonance assignments of alpha synuclein fibrils amplified from Lewy Body Dementia tissue.
| S-EPMC10863844 | biostudies-literature
Unknown Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.
| S-EPMC11800946 | biostudies-literature
Unknown Network dysfunction in α-synuclein transgenic mice and human Lewy body dementia.
| S-EPMC4693622 | biostudies-literature
Unknown Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
| S-EPMC149956 | biostudies-literature
Unknown Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.
| S-EPMC3204802 | biostudies-literature
Unknown Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.
| S-EPMC4372899 | biostudies-literature
Unknown Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
| S-EPMC8862415 | biostudies-literature
Unknown α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice.
| S-EPMC10613245 | biostudies-literature
Unknown Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.
| S-EPMC2785290 | biostudies-literature